| 2025-09-15 |
复牌提示：
2025-09-15 10:49:37 停牌，复牌日期 2025-09-15 10:59:37
|
| 2025-09-12 |
详情>>
股本变动：
变动后总股本702.05万股
|
| 2025-08-27 |
详情>>
业绩披露：
2024年年报每股收益-4.3美元,归母净利润-2514.9万美元,同比去年增长-43.15%
|
| 2024-12-31 |
详情>>
业绩披露：
2024年中报每股收益-1.08美元,归母净利润-631.2万美元,同比去年增长44.24%
|
| 2024-05-15 |
详情>>
业绩披露：
2021年年报每股收益-4.14美元,归母净利润-1720.2万美元,同比去年增长-24.24%
|
| 2024-05-15 |
详情>>
业绩披露：
2023年年报每股收益-3美元,归母净利润-1756.8万美元,同比去年增长8.06%
|
| 2024-04-05 |
股东大会：
将于2024-04-25召开股东大会
会议内容 ▼▲
- 1.Approval of the fixed compensation of the interim chief financial officer of the Company (the “CFO”) in excess of the Company’s Compensation Policy as approved by the shareholders of the Company on December 18, 2023 (we refer to this proposal as the “CFO Compensation Proposal”).
2.Approval of the compensation of the interim chief executive officer of the Company (the “CEO”) (we refer to this proposal as the “CEO Compensation Proposal”).
3.Ratification and approval of the appointment of Mr. Paul Medeiros who was previously duly appointed by the Company’s board of directors (the “Board”) to fill in vacancy on the Board, to hold office as member of the Board until the next annual meeting of shareholders of the Company, or until his earlier resignation of removal.
4.Ratification and approval of the appointment of Ms. Kyla Falkiner who was previously duly appointed by the Board to fill in vacancy on the Board, to hold office as member of the Board until the next annual meeting of shareholders of the Company, or until his earlier resignation of removal.
5.Ratification and approval of the appointment of Mr. Michael Hutton who was previously duly appointed by the Board to fill in vacancy on the Board, to hold office as member of the Board until the next annual meeting of shareholders of the Company, or until his earlier resignation of removal.
6.Ratification and approval of the appointment of Mr. Daniel Kokiw who was previously duly appointed by the Board to fill in vacancy on the Board, to hold office as member of the Board until the next annual meeting of shareholders of the Company, or until his earlier resignation of removal.
7.Ratification and approval of the appointment of Mr. David Lontini who was previously duly appointed by the Board to fill in vacancy on the Board, to hold office as member of the Board until the next annual meeting of shareholders of the Company, or until his earlier resignation of removal (we refer to Proposals 3, 4, 5, 6, and 7, collectively, as the “Board Ratification and Approval of Appointment Proposals”).
8.Approval of the removal of Mr. Idan Ben-Shitrit from his position as a member of the Board (we refer to this proposal as the “Board Member Removal Proposal”).
9.Approval of Fahn Kanne, as the independent auditor of the Company for the year ended December 31, 2023, and for such additional period until the next General Meeting of Shareholders of the Company, and approval to grant the Board with the authority to determine Fahn Kanne’s compensation (we refer to this proposal as the “Engagement of the Independent Auditor Proposal”).
|
| 2023-11-27 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-2.38美元,归母净利润-1391万美元,同比去年增长9.65%
|
| 2023-11-13 |
股东大会：
将于2023-12-18召开股东大会
会议内容 ▼▲
- 1.To approve, pursuant to Section 320 of the Israeli Companies Law 5759-1999 (the “Companies Law”), the merger of Capstone Merger Ltd., an Israeli company (“Israeli Merger Sub”) and a wholly-owned subsidiary of Capstone Dental Pubco, Inc., a Delaware corporation (“New Parent”) with and into Check-Cap, with Check-Cap surviving and becoming a wholly-owned subsidiary of New Parent, including approval of: (x) the Business Combination Agreement, dated as of August 16, 2023, by and among New Parent, Keystone Dental Holdings, Inc., a Delaware corporation (“Keystone”), Check-Cap, U.S. Merger Sub (as defined below) and Israeli Merger Sub (the “Business Combination Agreement”), pursuant to which, Capstone Merger Sub Corp., a Delaware corporation (“U.S. Merger Sub”, and, together with Israeli Merger Sub, the “Merger Subs”), and wholly-owned subsidiary of New Parent, will merge (the “U.S. Merger”) with and into Keystone, with Keystone surviving as a wholly-owned subsidiary of New Parent, and Israeli Merger Sub will merge (the “Israeli Merger,” and collectively with the U.S. Merger and the other transactions described in the Business Combination Agreement, the “Business Combination”) with and into Check-Cap, with Check-Cap surviving (which we refer to for the periods at and after the effective time of the Israeli Merger as the “Israeli Surviving Company”), and each of U.S. Merger Sub and Israeli Merger Sub will cease to exist, and (y) all other transactions and arrangements to which Check-Cap is a party contemplated by the Business Combination Agreement, a copy of which is attached as Exhibit 99.1 to the Company’s Form 6-K furnished to the U.S. Securities and Exchange Commission on August 17, 2023 (we refer to this proposal collectively as the “Business Combination Proposal”). If the Israeli Merger is completed, you will be entitled to receive one share of common stock, par value $0.01 per share, of New Parent (which we refer to as Parent Common Stock) in exchange for each ordinary share, par value NIS 48.00 per share, of Check-Cap (which we refer to as an Ordinary Share) that you hold as of immediately prior to the effective time of the Israeli Merger (as may be adjusted if Proposal 4 is approved at the Meeting and a reverse share split of the Company’s ordinary shares is implemented);
2.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., Certified Public Accountants, a firm in the Deloitte Global Network, as our independent auditor for the year ending December 31, 2023 and for such additional period until our next annual general meeting of shareholders;
3.To approve an amended and restated Compensation Policy for Executive Officers and Directors;
4.To approve a reverse share split of the Company’s ordinary shares within a range of 1 for 2 to 1 for 5, the exact ratio to be determined by further action of our Board of Directors, to be effective on a date to be determined by our Board of Directors and announced by the Company, and to amend our Articles of Association accordingly;
5.To elect five directors as members of the Company’s board of directors (the “Check-Cap Board”) out of the following ten director nominees proposed for election at the Meeting, each to serve until our next annual general meeting of shareholders and until their respective successors are duly elected and qualified: Steven Hanley, Clara Ezed, Dr. Mary Jo Gorman, XiangQian (XQ) Lin, Yuval Yanai (collectively, the “Company Director Nominees”), Idan Ben Shitrit, Avital Shafran, Jordan Lipton, William Vozzolo and Lilian Malczewski (collectively, the “Shareholder Director Nominees” and together with the Company Director Nominees, the “Director Nominees”) (we refer to this proposal collectively as the “Director Election Proposal”);
6.To approve the cash remuneration to be paid to the Director Nominees who are elected to serve as directors at the Meeting under Proposal 5;
7.To approve the Company’s entry into indemnification and exculpation agreements and to provide directors’ and officers’ liability insurance coverage to a Shareholder Director Nominee who is elected to serve at the Meeting under Proposal 5 (if any).
|
| 2023-11-01 |
股东大会：
将于2023-12-04召开股东大会
会议内容 ▼▲
- 1.A proposal to approve, pursuant to Section 320 of the Israeli Companies Law 5759-1999 (the “Companies Law”), the merger of Capstone Merger Ltd., an Israeli company (“Israeli Merger Sub”) and a wholly-owned subsidiary of Capstone Dental Pubco, Inc., a Delaware corporation (“New Parent”) with and into Check-Cap, with Check-Cap surviving and becoming a wholly-owned subsidiary of New Parent, including approval of: (x) the Business Combination Agreement, dated as of August 16, 2023, by and among New Parent, Keystone Dental Holdings, Inc., a Delaware corporation (“Keystone”), Check-Cap, U.S. Merger Sub (as defined below) and Israeli Merger Sub (the “Business Combination Agreement”), pursuant to which, Capstone Merger Sub Corp., a Delaware corporation (“U.S. Merger Sub”, and, together with Israeli Merger Sub, the “Merger Subs”), and wholly-owned subsidiary of New Parent, will merge (the “U.S. Merger”) with and into Keystone, with Keystone surviving as a wholly-owned subsidiary of New Parent, and Israeli Merger Sub will merge (the “Israeli Merger,” and collectively with the U.S. Merger and the other transactions described in the Business Combination Agreement, the “Business Combination”) with and into Check-Cap, with Check-Cap surviving (which we refer to for the periods at and after the effective time of the Israeli Merger as the “Israeli Surviving Company”), and each of U.S. Merger Sub and Israeli Merger Sub will cease to exist, and (y) all other transactions and arrangements to which Check-Cap is a party contemplated by the Business Combination Agreement, a copy of which is attached as Annex A to the prospectus filed by New Parent with the U.S. Securities and Exchange Commission as part of a registration statement on Form S-4 on October 26, 2023, in connection with the transactions contemplated under the Business Combination Agreement, which will be furnished to you together with the Proxy Statement to be delivered in connection with the Meeting (we refer to this proposal collectively as the “Business Combination Proposal”). . If the Israeli Merger is completed, you will be entitled to receive one share of common stock, par value $0.01 per share, of New Parent (which we refer to as Parent Common Stock) in exchange for each ordinary share, par value NIS 48.00 per share, of Check-Cap (which we refer to as an Ordinary Share) that you hold as of immediately prior to the effective time of the Israeli Merger.
2.A proposal to elect five directors as members of the Company’s board of directors (the “Check-Cap Board”) out of the following ten director nominees proposed for election at the Meeting, each to serve until our next annual general meeting of shareholders and until their respective successors are duly elected and qualified: Steven Hanley, Clara Ezed, Dr. Mary Jo Gorman, XiangQian (XQ) Lin, Yuval Yanai (collectively, the “Company Director Nominees”), Idan Ben Shitrit, Avital Shafran, Jordan Lipton, William Vozzolo and Lilian Malczewski (collectively, the “Shareholder Director Nominees” and together with the Company Director Nominees, the “Director Nominees”) (we refer to this proposal collectively as the “Director Election Proposal”).
|
| 2023-08-04 |
详情>>
业绩披露：
2023年中报每股收益-1.94美元,归母净利润-1132万美元,同比去年增长-6.38%
|
| 2023-05-11 |
详情>>
业绩披露：
2023年一季报每股收益-0.76美元,归母净利润-444.2万美元,同比去年增长23.86%
|
| 2023-03-31 |
详情>>
业绩披露：
2022年年报每股收益-3.37美元,归母净利润-1910.8万美元,同比去年增长-11.08%
|
| 2022-11-30 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.14美元,归母净利润-1539.5万美元,同比去年增长-31.3%
|
| 2022-11-25 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2022-11-09 |
股东大会：
将于2022-12-22召开股东大会
会议内容 ▼▲
- 1.To re-elect all five directors as members of our Board of Directors, each to serve until our next annual general meeting of shareholders and until their respective successors are duly elected and qualified
2.To approve the remuneration to be paid to each of the director nominees, subject to their re-election at the Meeting
3.To approve a one-time award of options to each of the director nominees, subject to their re-election at the Meeting
4.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., Certified Public Accountants, a firm in the Deloitte Global Network, as our independent auditor for the year ending December 31,2022 and for such additional period until our next annual general meeting of shareholders
5.To review and discuss our financial statements for the year ended December 31,2021
|
| 2022-08-31 |
详情>>
业绩披露：
2022年中报每股收益-0.1美元,归母净利润-1064.1万美元,同比去年增长-42.18%
|
| 2022-08-04 |
股东大会：
将于2022-08-11召开股东大会
|
| 2022-06-22 |
股东大会：
将于2022-08-04召开股东大会
|
| 2021-10-21 |
股东大会：
将于2021-12-02召开股东大会
会议内容 ▼▲
- 1.To re-elect all five directors to serve as members of our Board of Directors, until our next annual general meeting of shareholders and until their respective successors are duly elected;
2.To approve the remuneration to be paid to each of the director nominees, subject to their re-election at the Meeting;
3.To approve amended annual bonus terms for Mr. Alex Ovadia, our Chief Executive Officer, and a one-time award of options to Mr. Ovadia;
4.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., Certified Public Accountants, a firm in the Deloitte Global Network, as our independent auditor for the year ending December 31, 2021 and for such additional period until our next annual general meeting;
5.To review and discuss our financial statements for the year ended December 31, 2020.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-21 |
股东大会：
将于2020-12-03召开股东大会
会议内容 ▼▲
- 1.To re-elect all five directors to serve as members of our Board of Directors, until our next annual general meeting of shareholders and until their respective successors are duly elected;
2.To approve the remuneration to be paid to each of the director nominees, subject to their re-election at the Meeting;
3.To approve an increase of our authorized and registered share capital and to amend our Articles of Association accordingly;
4.To approve a reverse share split of our ordinary shares within a range of 1 for 10 to 1 for 20, the exact ratio to be determined by further action of our Board of Directors, to be effective on a date to be determined by our Board of Directors and announced by the Company, and to amend our Articles of Association (as may be amended, if Proposal 3 is approved at the Meeting) accordingly;
5.To approve an amended and restated Compensation Policy for Executive Officers and Directors in accordance with the requirements of Israeli law;
6.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., Certified Public Accountants, a firm in the Deloitte Global Network, as our independent auditor for the year ending December 31, 2020 and for such additional period until our next annual general meeting;
7.To review and discuss our financial statements for the year ended December 31, 2019.
|
| 2019-10-23 |
股东大会：
将于2019-12-05召开股东大会
会议内容 ▼▲
- 1.To re-elect all five directors to serve as members of our Board of Directors, until our next annual general meeting of shareholders;
2.To approve the remuneration to be paid to each of the director nominees, subject to their re-election at the Meeting;
3.To approve a one-time award of equity-based compensation, consisting of performance-based restricted stock units and options, to each of the director nominees, subject to their re-election at the Meeting;
4.To approve a one-time award of equity-based compensation, consisting of performance-based restricted stock units and options, to Alex Ovadia, our Chief Executive Officer;
5.To approve an increase of our authorized and registered share capital by NIS 144,000,000 and to amend our Articles of Association accordingly;
6.To approve an amendment to our Compensation Policy for Executive Officers and Directors, with respect to the maximum aggregate annual premium and maximum aggregate deductible payable for directors’ and officers’ liability insurance;
7.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., Certified Public Accountants, a firm in the Deloitte Global Network, as our independent auditor for the year ending December 31, 2019 and for such additional period until our next annual general meeting;
8.To review and discuss our financial statements for the year ended December 31, 2018.
|
| 2018-12-19 |
股东大会：
将于2018-12-20召开股东大会
会议内容 ▼▲
- 1.To approve amended compensation terms for Mr. Alex Ovadia, our Chief Executive Officer;
2.To approve a one-time award of equity-based compensation, consisting of restricted stock units and options, to Mr. Alex Ovadia, our Chief Executive Officer.
|
| 2018-08-01 |
股东大会：
将于2018-09-13召开股东大会
会议内容 ▼▲
- 1.To re-elect all five directors to serve as members of our Board of Directors, until our next annual general meeting of shareholders;
2.To approve the remuneration to be paid to each of the director nominees, subject to their election at the Meeting;
3.To approve a one-time award of equity-based compensation, consisting of restricted stock units and options, to each of the director nominees, subject to their election at the Meeting;
4.To approve amended compensation terms for, and a one-time award of equity-based compensation, consisting of restricted stock units and options to, Mr. Alex Ovadia, our Chief Executive Officer;
5.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., a member of Deloitte Touche Tohmatsu, as our independent auditor for the year ending December 31, 2018 and for such additional period until our next annual general meeting;
6.To review and discuss our financial statements for the year ended December 31, 2017.
|
| 2018-05-21 |
股东大会：
将于2018-06-14召开股东大会
会议内容 ▼▲
- 1.to approve an increase of the Company’s authorized and registered share capital by NIS 48,000,000 and to amend the Company’s Articles of Association accordingly.
|
| 2018-04-04 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2018-03-01 |
股东大会：
将于2018-04-02召开股东大会
会议内容 ▼▲
- 1.To approve an increase of the Company’s authorized and registered share capital by NIS 12,500,000 and to amend our Articles of Association accordingly;
2.To approve a reverse share split of the Company’s ordinary shares within a range of 1:8 to 1:12, the exact ratio to be determined by further action of our Board of Directors, to be effective on a date to be determined by our Board of Directors and announced by the Company, and to amend our Articles of Association (as may be amended, if Proposal 1 is approved at the Meeting) accordingly;
3.To approve the terms of engagement of Mr. Alex Ovadia, as Chief Executive Officer.
|
| 2016-11-23 |
股东大会：
将于2016-12-22召开股东大会
会议内容 ▼▲
- 1.To re-elect five directors to serve as members of our Board of Directors (in addition to the two external directors under Israeli law), until our next annual general meeting of shareholders;
2.To approve the compensation to be paid to each of the non-employee directors (other than the Chairman of the Board of Directors and the external directors under Israeli law), subject to their election at the Meeting;
3.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., a member of Deloitte Touche Tohmatsu, as our independent auditor for the year ending December 31, 2016 and for such additional period until our next annual general meeting;
4.To approve the payment to our Chief Executive Officer of the discretionary component of the annual bonus for the year ended December 31, 2015;
5.To approve the payment to our Chief Technology Officer (who served as a director until December 2015) of the discretionary component of the annual bonus for the year ended December 31, 2015;
6.To review and discuss our financial statements for the year ended December 31, 2015.
|
| 2015-10-21 |
股东大会：
将于2015-12-01召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve as members of our Board of Directors (in addition to the two external directors under Israeli law) until our next annual general meeting of shareholders;
2.To approve the compensation to be paid to each of the non-employee directors (other than the Chairman of the Board and the external directors under Israeli law), subject to their election at the Meeting;
3.To ratify and approve the reappointment of Brightman Almagor Zohar & Co., a member of Deloitte Touche Tohmatsu, as our independent auditor for the year ending December 31, 2015 and for such additional period until our next annual general meeting;
4.To approve the payment of an annual cash bonus to Mr. Guy Neev, our former Chief Executive Officer;
5.To approve bonus objectives and payout terms for the period ending December 31, 2015 for our Chief Executive Officer;
6.To approve bonus objectives and payout terms for the period ending December 31, 2015 for our Chief Technology Officer;
7.To amend Articles 45(a) of our articles of association regarding the appointment of alternate directors;
8.To review and discuss our financial statements for the year ended December 31, 2014.
|
| 2015-07-06 |
股东大会：
将于2015-08-13召开股东大会
会议内容 ▼▲
- 1.To approve the adoption of the Check-Cap Ltd. Compensation Policy for Executive Officers and Directors;
2.To approve the adoption of the Check-Cap Ltd. 2015 Equity Incentive Plan and the Check-Cap Ltd. 2015 United States Sub-Plan to the 2015 Equity Incentive Plan for U.S. tax purposes;
3.To approve the terms of engagement of Mr. William Densel, as Chief Executive Officer.
|
| 2015-04-08 |
股东大会：
将于2015-05-19召开股东大会
会议内容 ▼▲
- 1.To ratify the election of, or elect, each of the following as external directors, within the meaning of the Israeli Companies Law, 5759-1999: (i) Mr. Yuval Yanai; and (ii) Ms. Mary Jo Gorman, each for an initial three-year term;
2.Subject to the approval of Proposal 1, to ratify and approve the compensation to be paid to each of the external directors, consisting of an annual fee and a one-time option grant;
3.To approve the terms of engagement of Mr. Bill Densel, as President of U.S. Operations.
|